Data as of Jan 27
| +0.64 / +0.97%|
The 21 analysts offering 12-month price forecasts for St. Jude Medical have a median target of 74.00, with a high estimate of 84.00 and a low estimate of 47.00. The median estimate represents a +11.06% increase from the last price of 66.63.
The current consensus among 23 polled investment analysts is to Buy stock in St. Jude Medical. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.